Quick Summary
- Early-access invitations reportedly list Temple at ₹85,000, including a lifetime subscription; final pricing has not been formally confirmed.
- The device uses optical sensors to track changes in cerebral blood flow and calculates a company-defined Entropy score for physiological strain.
- Temple is positioned as a wellness and research product, not a medical device intended to diagnose health conditions.
Temple is moving from concept toward a limited commercial release, with early-access invitations reportedly listing the device at ₹85,000. NDTV Profit reported on October 25 that the price includes a lifetime subscription to the platform and that preorders for the first batch are scheduled to open on November 1, 2026. The company has not formally confirmed the reported price, so it should be treated as an early-access figure rather than a guaranteed final retail price. That distinction matters for a product whose first production run is expected to be limited.
According to the report, selected users have received invitations through the Temple app. The first batch is expected to be made by hand after each order, and Goyal has previously said buyers should receive their devices within three months of ordering. The company has not publicly disclosed how many units will be available. A limited, made-to-order launch can help a young hardware business manage production risk, but it also means early buyers should look carefully at providey terms, cancellation rules and what happens if the schedule changes.
A premium price for a specialised sensor
Temple can measure changes in blood flow to the brain using optical sensors. The company calls this metric BrainFlow and also generates an Entropy score ranging from 1 to 250, intended to indicate physiological strain. The report says sleep, exercise, stress and caffeine may influence the score. These measurements are not interchangeable with a medical diagnosis: the device is positioned as a wellness and research product rather than a tool approved to diagnose a health condition. Buyers So need to understand both what the company says it measures and what it does not claim to establish.
The hardware attaches to the side of the head with single-use adhesive strips called Grips. That form factor is different from a watch or ring, which generally sits on a wrist or finger and can fit into an established daily routine. Temple’s longer-term appeal will depend on whether users find the placement comfortable, whether readings remain consistent across ordinary activities and how clearly the software explains changes over time. A technically sophisticated sensor is only useful to most consumers if its output can be interpreted without requiring them to become specialists in physiology.
Interpreting BrainFlow and Entropy scores
The reported ₹85,000 price places Temple in a premium category. Consumers are likely to compare it with other devices and services that promise to help them understand sleep, stress or performance. A lifetime subscription may reduce recurring fees, but it does not by itself prove that the device will produce useful insights over several years. Buyers should check what the subscription covers, whether software features can change and what support is available if the company revises its platform. The product’s value will depend on the data and services provideed after the initial purchase.
Independent validation will be important because a new physiological metric can sound more definitive than the available evidence warrants. Useful questions include how the sensor was evaluated, how repeatable readings are, what sources of error are known and whether the score has been compared with established measurements. The available report does not establish that Temple can predict disease or replace professional assessment. Such claims should not be inferred from the fact that the device monitors a signal associated with the brain.
The launch is a test of whether a niche monitoring concept can become a product people use consistently rather than a novelty bought out of curiosity. The clearest evidence will come after customers receive devices: whether they keep wearing them, understand the readings and find that the information changes a decision in a useful way. Until then, the preorder date and reported price are the most concrete commercial details, while the value of the measurements remains a question for real-world use and independent assessment.